173 related articles for article (PubMed ID: 38155279)
1. Targeting lncRNA16 by GalNAc-siRNA conjugates facilitates chemotherapeutic sensibilization via the HBB/NDUFAF5/ROS pathway.
Liu Y; Wang Y; Liu B; Liu W; Ma Y; Cao Y; Yan S; Zhang P; Zhou L; Zhan Q; Wu N
Sci China Life Sci; 2024 Apr; 67(4):663-679. PubMed ID: 38155279
[TBL] [Abstract][Full Text] [Related]
2. LncRNA16 is a potential biomarker for diagnosis of early-stage lung cancer that promotes cell proliferation by regulating the cell cycle.
Zhu H; Zhang L; Yan S; Li W; Cui J; Zhu M; Xia N; Yang Y; Yuan J; Chen X; Luo J; Chen R; Xing R; Lu Y; Wu N
Oncotarget; 2017 Jan; 8(5):7867-7877. PubMed ID: 27999202
[TBL] [Abstract][Full Text] [Related]
3. Metformin reverses chemoresistance in non-small cell lung cancer via accelerating ubiquitination-mediated degradation of Nrf2.
Huang S; He T; Yang S; Sheng H; Tang X; Bao F; Wang Y; Lin X; Yu W; Cheng F; Lv W; Hu J
Transl Lung Cancer Res; 2020 Dec; 9(6):2337-2355. PubMed ID: 33489797
[TBL] [Abstract][Full Text] [Related]
4. PCK1-mediated glycogenolysis facilitates ROS clearance and chemotherapy resistance in cervical cancer stem cells.
Chen X; Yang N; Wang Y; Yang S; Peng Y
Sci Rep; 2024 Jun; 14(1):13670. PubMed ID: 38871968
[TBL] [Abstract][Full Text] [Related]
5. Blocking hsa_circ_0074027 suppressed non-small cell lung cancer chemoresistance via the miR-379-5p/IGF1 axis.
Zheng S; Wang C; Yan H; Du Y
Bioengineered; 2021 Dec; 12(1):8347-8357. PubMed ID: 34592879
[TBL] [Abstract][Full Text] [Related]
6. Self-targeted knockdown of CD44 improves cisplatin sensitivity of chemoresistant non-small cell lung cancer cells.
Quan YH; Lim JY; Choi BH; Choi Y; Choi YH; Park JH; Kim HK
Cancer Chemother Pharmacol; 2019 Mar; 83(3):399-410. PubMed ID: 30515553
[TBL] [Abstract][Full Text] [Related]
7. LncRNA LINC00942 promotes chemoresistance in gastric cancer by suppressing MSI2 degradation to enhance c-Myc mRNA stability.
Zhu Y; Zhou B; Hu X; Ying S; Zhou Q; Xu W; Feng L; Hou T; Wang X; Zhu L; Jin H
Clin Transl Med; 2022 Jan; 12(1):e703. PubMed ID: 35073459
[TBL] [Abstract][Full Text] [Related]
8. KIAA1522 potentiates TNFα-NFκB signaling to antagonize platinum-based chemotherapy in lung adenocarcinoma.
Wang B; Jing T; Jin W; Chen J; Wu C; Wang M; Liu Y
J Exp Clin Cancer Res; 2020 Aug; 39(1):170. PubMed ID: 32854746
[TBL] [Abstract][Full Text] [Related]
9. Musashi1 Promotes Non-Small Cell Lung Carcinoma Malignancy and Chemoresistance via Activating the Akt Signaling Pathway.
Lang Y; Kong X; He C; Wang F; Liu B; Zhang S; Ning J; Zhu K; Xu S
Cell Physiol Biochem; 2017; 44(2):455-466. PubMed ID: 29141252
[TBL] [Abstract][Full Text] [Related]
10. Glutathione Peroxidase 1 Promotes NSCLC Resistance to Cisplatin via ROS-Induced Activation of PI3K/AKT Pathway.
Chen B; Shen Z; Wu D; Xie X; Xu X; Lv L; Dai H; Chen J; Gan X
Biomed Res Int; 2019; 2019():7640547. PubMed ID: 31032363
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial ROS drive resistance to chemotherapy and immune-killing in hypoxic non-small cell lung cancer.
Salaroglio IC; Belisario DC; Akman M; La Vecchia S; Godel M; Anobile DP; Ortone G; Digiovanni S; Fontana S; Costamagna C; Rubinstein M; Kopecka J; Riganti C
J Exp Clin Cancer Res; 2022 Aug; 41(1):243. PubMed ID: 35953814
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of lncRNA-XIST enhances the chemosensitivity of NSCLC cells via suppression of autophagy.
Sun W; Zu Y; Fu X; Deng Y
Oncol Rep; 2017 Dec; 38(6):3347-3354. PubMed ID: 29130102
[TBL] [Abstract][Full Text] [Related]
13. LncRNA SNHG7 promotes non-small cell lung cancer progression and cisplatin resistance by inducing autophagic activity.
She K; He S; Lu X; Yu S; Li M; Xiong W; Zhou M
J Thorac Dis; 2023 Jan; 15(1):155-167. PubMed ID: 36794139
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy-induced PDL-1 expression in cancer-associated fibroblasts promotes chemoresistance in NSCLC.
Heenatigala Palliyage G; Samart P; Bobbala S; Rojanasakul LW; Coyle J; Martin K; Callery PS; Rojanasakul Y
Lung Cancer; 2023 Jul; 181():107258. PubMed ID: 37245409
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of PDGFR by CP-673451 induces apoptosis and increases cisplatin cytotoxicity in NSCLC cells via inhibiting the Nrf2-mediated defense mechanism.
Yang Y; Deng Y; Chen X; Zhang J; Chen Y; Li H; Wu Q; Yang Z; Zhang L; Liu B
Toxicol Lett; 2018 Oct; 295():88-98. PubMed ID: 29857117
[TBL] [Abstract][Full Text] [Related]
16. LncRNA BLACAT1 is involved in chemoresistance of non‑small cell lung cancer cells by regulating autophagy.
Huang FX; Chen HJ; Zheng FX; Gao ZY; Sun PF; Peng Q; Liu Y; Deng X; Huang YH; Zhao C; Miao LJ
Int J Oncol; 2019 Jan; 54(1):339-347. PubMed ID: 30387831
[TBL] [Abstract][Full Text] [Related]
17. A Novel lncRNA FUAT1/TNS4 Axis Confers Chemoresistance by Suppressing Reactive Oxygen Species-Mediated Apoptosis in Gastric Cancer.
Liu M; Li H; Li X; Pan B; Zhang J; Pan Y; Shen M; Liu L
Antioxid Redox Signal; 2023 Nov; ():. PubMed ID: 37658838
[No Abstract] [Full Text] [Related]
18. CXCR4 promotes cisplatin-resistance of non-small cell lung cancer in a CYP1B1-dependent manner.
Xie S; Tu Z; Xiong J; Kang G; Zhao L; Hu W; Tan H; Tembo KM; Ding Q; Deng X; Huang J; Zhang Q
Oncol Rep; 2017 Feb; 37(2):921-928. PubMed ID: 27922681
[TBL] [Abstract][Full Text] [Related]
19. Epiregulin increases stemness-associated genes expression and promotes chemoresistance of non-small cell lung cancer via ERK signaling.
Zhang Y; Qiu F; Ye T; Lee SH; Xu J; Jia L; Zeng R; Wang X; Hu X; Yan X; Li H; Lu Y; Wang X; Jiang R; Xu W
Stem Cell Res Ther; 2022 May; 13(1):197. PubMed ID: 35551652
[TBL] [Abstract][Full Text] [Related]
20. CircHERC1 promotes non-small cell lung cancer cell progression by sequestering FOXO1 in the cytoplasm and regulating the miR-142-3p-HMGB1 axis.
Cui Y; Wu X; Jin J; Man W; Li J; Li X; Li Y; Yao H; Zhong R; Chen S; Wu J; Zhu T; Lin Y; Xu J; Wang Y
Mol Cancer; 2023 Nov; 22(1):179. PubMed ID: 37932766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
